| Name | : | Shrikant Mandlik |
| Website | : | Visit Website |
| Blog | : | Visit Blog |
| Social Links | : |
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information.
Shrikant Mandlik20 Oct, 2022Health
The global urology devices market was valued at US$ 38 Bn in 2021 The global market is projected to expand at a CAGR of 5.6% from 2022 to 2031 The global urology devices market is anticipated to surpass US$ 64 Bn by 2031 Due to rising incidence of urologic conditions, medical device manufacturers are increasing their production capabilities to manufacture efficient and safe urological devices. Urinary incontinence is a common yet critical problem of urinary disorder wherein a patient loses control over urine. Besides in the elderly population, women are commonly affected with the medical condition of urinary incontinence. Data published by the urinaryincontinence.com states that one in three women in the U.S. suffers from some form of urinary incontinence.
Shrikant Mandlik19 Oct, 2022Health
According to the report, the global sports medicine devices market was valued at US$ 9.08 Bn in 2020 and is projected to expand at a CAGR of 5.6% from 2021 to 2028. The sports medicine devices market is witnessing strong growth due to increase in demand for doctors, surgeons, nurses, physical therapists, and other healthcare professionals specialized in the field. This can be attributed to rise in unmet needs of providing effective treatment for various types of condition restricting the physical activities due to sports injuries.
Shrikant Mandlik18 Oct, 2022Health
U.S. Dry Eye Disease Diagnostic Devices Market: Introduction According to the report, the dry eye disease diagnostic devices market in the U.S. was valued at US$ 58.3 Mn in 2020 and is projected to expand at CAGR of 4.4% from 2021 to 2031. Dry eye disease diagnostic devices include anterior segment OCT (AS-OCT), meibography device, corneal topographer, and osmolarity testing device. The usage of dry eye disease diagnostic devices can be classified based on the parameter measured into tear film osmolarity, tear turnover, functional visual acuity, tear volume, tear film stability, tear film composition, ocular biomarkers, and others.
Shrikant Mandlik17 Oct, 2022Health
According to the report, the global veterinary molecular diagnostics market was valued at US$ 479.3 Mn in 2019 and is projected to expand at a CAGR of ~8% from 2020 to 2030. Molecular diagnostics are laboratory methods to examine the RNA, DNA, or other proteins in animals and identify diseases or the predisposition stage. Different technologies are used in the diagnosis of veterinary diseases, including conventional PCR, singleplex PCR, multiplex PCR, and real-time PCR. The growth of the global veterinary molecular diagnostics market can be ascribed to increase in zoonotic disease concerns and rise in pet ownership & spending in the pet industry. North America dominated the global veterinary molecular diagnostics market in 2019.
Shrikant Mandlik14 Oct, 2022Health
According to the report, the global drug device combination products market was valued at US$ 120.0 Bn in 2020 and is projected to expand at a CAGR of 7.3% from 2021 to 2028. Drug-device combination products are defined as therapeutic products comprising an active pharmaceutical ingredient and a medical device that are physically and/or chemically combined to be produced as a single product. Increase in incidence of chronic diseases such as diabetes, cancer, and respiratory problems; rise in casualties due to accidents & trauma, surge in the geriatric population, growth of the home-based healthcare market, and technological advancements such as the development of prefilled syringes boost the growth of the global drug-device combination products market.
Shrikant Mandlik12 Oct, 2022Health
Corporate Wellness Market Outlook ? The global corporate wellness market was valued at US$ 40.2 Bn in 2020 ? It is estimated to expand at a CAGR of 8.2% from 2021 to 2028 ? The global corporate wellness market is expected to cross the value of US$ 74.5 Bn by the end of 2028
Shrikant Mandlik11 Oct, 2022Health
Due to consistent advancements in the cardiovascular medicine field, stenting of the arteries has emerged as one of the most common and popular cardiovascular treatment. As stenting continues to gain popularity across the world, the demand for vascular stents continues to gain considerable traction. The alarming rise in the number of patients suffering from cardiovascular diseases has compelled the medical sector to focus on new treatments and medical concepts to improve the recovery rate of existing treatments. At present, existing technologies, particularly related to drug-eluting stents have witnessed rapid developments.
Shrikant Mandlik10 Oct, 2022Health
ECG Devices Market Outlook 2031 ? The global ECG devices market was valued at US$ 5.6 Bn in 2021 ? It is projected to grow at a CAGR of 7.3% from 2022 to 2031 ? The global ECG devices market is anticipated to reach US$ 11.6 Bn by the end of 2031
Shrikant Mandlik07 Oct, 2022Health
The American Academy of Ophthalmology (AAO) has recommended ophthalmologists to cease providing non-urgent care during the ongoing coronavirus pandemic. The institute has also provided a list of urgent and emergent procedures required to solve potential sight-threatening conditions. Such findings are affecting and influencing the growth of the amblyopia treatment market.
Shrikant Mandlik06 Oct, 2022Health
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body?s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help in diagnosing the health of patients. The U.S. Food and Drug Administration (FDA) has approved the usage of biomarkers as surrogate end-points in the treatment development process.
91club Wtf
Lillypad
Garfield Amor Clifton Garage
88nnlat
Khalifasaleh
Epoxy Tile Grout Singapore
Trang Chủ F168
Blue Ocean Strategy & Service
Ananas777
Reddy Anna Official